Trial intelligence / Profile preview

Comparison of Metoclopramide, Promethazine, and Prochloroperazine for Acute Vertigo

NCT05586763Phase 3Recruiting

Sponsor
Oman Medical Specialty Board
Start
Feb 2022
Primary completion
Dec 2024
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of metoclopramide, promethazine, prochlorperazine in Peripheral vertigo, sponsored by Oman Medical Specialty Board. Started Feb 2022; status: recruiting.

02

Drugs

metoclopramidepromethazineprochlorperazine
03

Conditions

Peripheral vertigo

Beyond the preview

Go deeper on NCT05586763.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05586763.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call